TABLE 3.
Perioperative Mental Health Intervention Session Details
| Cardiac | Orthopedic | Oncologic | Total | ||
|---|---|---|---|---|---|
| Mean number of total sessions | 7.8 | 8.5 | 7.7 | 8.0 | |
| Mean number of preoperative sessions | 1.4 | 2.9 | 1.9 | 2.1 | |
| Mean number of postoperative sessions | 6.4 | 5.6 | 5.8 | 5.9 | |
| Mean number of wellness program sessions | 7.3 | 7.9 | 7.3 | 7.5 | |
| Mean number of medication optimization sessions | 3.7 | 1.4 | 2.4 | 2.5 | |
| Mean session duration (minutes) | 39.0 | 44.8 | 40.8 | 41.4 | |
| Session modality (n) | Telephone | 66 | 59 | 53 | 178 |
| Zoom | 0 | 0 | 2 | 2 | |
| In person | 0 | 0 | 2 | 2 | |
| Mean number of medications at baseline | 20.6 | 15.8 | 15.6 | 17.3 | |
| Number of medications eligible for deprescribing Deprescribing outcomes |
12 | 4 | 7 | 23 | |
| Implemented | 3 | 2 | 2 | 7 | |
| Not Implemented | 6 | 2 | 4 | 12 | |
| Othera | 3 | 0 | 1 | 4 | |
| Number of antidepressants eligible for dose escalation Antidepressant dose escalation outcomes |
5 | 3 | 0 | 8 | |
| Implemented | 3 | 0 | 0 | 3 | |
| Not Implemented | 2 | 1 | 0 | 3 | |
| Otherb | 0 | 2 | 0 | 2 | |
a
For deprescribing: one participant taking two target medications declined MO, but it both medications were discontinued by the clinical team. one participant decreased their intake frequency but did not discontinue the medication completely and one participant stopped taking the medication voluntary without discussion with the Wellness Partner.
b
For dose escalation, other refers to one participant for whom it was determined that the dose should not be increased for clinical reasons and one participant was still in consultation with their medical team about increasing the dosage when the study ended.